-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Opiant Pharmaceuticals, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2011 to 2021.
- Opiant Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2022 was $8.55K.
- Opiant Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2022 was $65.3K.
- Opiant Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2021 was $24.3K.
- Opiant Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2020 was -$426K, a 140% decline from 2019.
- Opiant Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2019 was -$177K, a 446% decline from 2018.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)